Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CROSSROADS TREATMENT CENTER OF SOMERSET, PSC

NPI: 1417452798 · SOMERSET, KY 42503 · Methadone Clinic · NPI assigned 03/28/2018

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official MCCORMAC, RUPERT controls 20+ related entities in our dataset. Read more

$7.19M
Total Medicaid Paid
210,345
Total Claims
39,391
Beneficiaries
24
Codes Billed
2018-09
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMCCORMAC, RUPERT (CHIEF EXECUTIVE OFFICER)
NPI Enumeration Date03/28/2018

Related Entities

Other providers sharing the same authorized official: MCCORMAC, RUPERT

ProviderCityStateTotal Paid
ARS TREATMENT CENTERS, P.C. UNIONTOWN PA $73.26M
STARTING POINT OF VIRGINIA, P.C. ABINGDON VA $28.98M
CROSSROADS TREATMENT CENTER OF DANVILLE, PC DANVILLE VA $18.63M
CROSSROADS TREATMENT CENTER OF WINCHESTER, PC WINCHESTER VA $14.07M
CROSSROADS TREATMENT CENTER OF LOUISVILLE, PSC JEFFERSONTOWN KY $13.68M
CROSSROADS TREATMENT CENTER OF PETERSBURG, PC SOUTH PRINCE GEORGE VA $12.61M
CROSSROADS TREATMENT CENTER OF GREENSBORO, PC GREENSBORO NC $11.06M
CROSSROADS TREATMENT CENTER OF SUFFOLK, PC SUFFOLK VA $7.68M
CROSSROADS TREATMENT CENTER OF ASHEVILLE, PC ASHEVILLE NC $6.45M
CENTER OF HOPE OF MYRTLE BEACH, LLC MYRTLE BEACH SC $5.62M
CROSSROADS TREATMENT CENTER OF NORTHERN KENTUCKY, PSC INDEPENDENCE KY $4.80M
STARTING POINT OF FLORENCE, INC FLORENCE SC $4.62M
CROSSROADS TREATMENT CENTER OF WEAVERVILLE, PC WEAVERVILLE NC $4.41M
CROSSROADS TREATMENT CENTER OF CHARLESTON, PC NORTH CHARLESTON SC $3.18M
CROSSROADS TREATMENT CENTER OF ASHLAND, PSC ASHLAND KY $2.64M
STARTING POINT OF DARLINGTON, LLC HARTSVILLE SC $2.27M
CROSSROADS TREATMENT CENTER OF SENECA, PC SENECA SC $1.93M
CROSSROADS TREATMENT CENTER OF DENVER, PC DENVER CO $1.78M
ARS TREATMENT CENTERS OF NEW JERSEY, PC LANOKA HARBOR NJ $1.65M
CROSSROADS TREATMENT CENTER OF GREENVILLE, PC GREENVILLE SC $1.57M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,579 $24K
2019 69,560 $589K
2020 65,315 $1.54M
2021 16,515 $1.26M
2022 16,859 $1.23M
2023 20,222 $1.41M
2024 20,295 $1.13M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
H0020 Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) 85,659 17,926 $5.52M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 89,248 3,489 $691K
T1007 Alcohol and/or substance abuse services, treatment plan development and/or modification 5,445 4,517 $324K
99408 7,626 614 $123K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2,304 2,119 $107K
H0016 Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) 583 519 $95K
90832 Psychotherapy, 30 minutes with patient 4,257 1,384 $73K
H0033 Oral medication administration, direct observation 912 758 $71K
99441 5,647 1,391 $63K
90791 Psychiatric diagnostic evaluation 1,558 1,089 $56K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,552 1,248 $31K
82075 2,750 2,400 $26K
90834 Psychotherapy, 45 minutes with patient 61 45 $2K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 122 87 $2K
99406 293 240 $1K
86580 321 307 $1K
G2067 Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) 263 87 $1K
36415 Collection of venous blood by venipuncture 324 310 $1K
80305 331 242 $778.46
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 13 12 $533.66
81025 120 119 $413.11
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 389 225 $156.59
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 175 36 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 392 227 $0.00